Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02GLM
|
||||
| Former ID |
DNC008936
|
||||
| Drug Name |
2,4-diisobutylamino-6-isopentylpyrimidine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529687] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C17H32N4
|
||||
| Canonical SMILES |
CC(C)CCC1=CC(=NC(=N1)NCC(C)C)NCC(C)C
|
||||
| InChI |
1S/C17H32N4/c1-12(2)7-8-15-9-16(18-10-13(3)4)21-17(20-15)19-11-14(5)6/h9,12-14H,7-8,10-11H2,1-6H3,(H2,18,19,20,21)
|
||||
| InChIKey |
FELVKNQXOFEZOY-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor | Target Info | Inhibitor | [529687] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| Plasma membrane estrogen receptor signaling | |||||
| LKB1 signaling events | |||||
| Regulation of Telomerase | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| FOXM1 transcription factor network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| FOXA1 transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.